Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...

GSK has built the case for first-line use of its PD-1 inhibitor Jemperli in endometrial cancer, with new survival data that could help it expand the label for the drug. The latest readout from the ...

GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in the RUBY trial.

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.

A curated review of what has happened in endometrial cancer research in 2024, including expert commentary, FDA approvals, healthcare disparities, AI, immunotherapies, and more.

MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...

Detailed price information for Anaptysbio Inc (ANAB-Q) from The Globe and Mail including charting and trades.

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial ...

Amit Shah vows anti-conversion law in Maharashtra, opposition caste census Union Home Minister Amit Shah, during the release of BJP's election manifesto in Mumbai, promised a stringent anti ...

Nov. 11, 2024 — Like the Earth, the Sun likely has swirling polar vortices, according to new research. But unlike on Earth, the formation and evolution of these vortices are driven by magnetic ...